About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Direct to Consumer Advertising in Europe Will Harm Public Health, Warn Experts

by Medindia Content Team on October 6, 2007 at 1:02 PM
Font : A-A+

Direct to Consumer Advertising in Europe Will Harm Public Health, Warn Experts

Allowing the drug industry to supply information on prescription medicines direct to patients in Europe will have serious implications for public health, warn experts in this week's BMJ.

The European parliament is considering allowing the drug industry to have a much greater role in providing information to patients, with no restriction on the type of media, write Les Toop and Dee Mangin from the University of Otago, New Zealand.

Advertisement

In New Zealand and the US, the only two developed countries that allow direct to consumer advertising of prescription medicines, opposition has grown steadily from both the public and doctors.

New Zealand's health system is much closer to those in Europe than the US system. So what can we learn from its experience, they ask?

Last year drug companies spent over $5bn on direct to consumer advertising in the US and tens of millions of dollars in New Zealand. But opposition grew alongside the advertising, and by 2000, New Zealand and US health watchdog groups were becoming more vocal.
Advertisement

The rising concern led the New Zealand Ministry of Health to start a public consultation in the same year. But the advertising was allowed to continue with self regulation and a promised further review of compliance with the rules never took place.

In this context, advertising became more widespread and proved extremely effective. For instance, intensive advertising of celcoxib and refecoxib on prime time television, aimed specifically at long term use in the elderly, resulted in widespread prescribing, despite early warnings of their cardiac risks. Similarly, just a few TV adverts promoting oral terbinafine for toenail infections resulted in a doubling of national prescriptions within weeks.

In response to mounting concern from the public and the professions, the New Zealand government resolved to ban direct to consumer advertising in late 2003. To date, the government has been unable to pass the necessary legislation, despite a recent round of consultation showing strong opposition from health professional groups and almost complete (90%) opposition from independent consumer and patient organisations.

The lesson from the New Zealand experience for Europe is clear, say the authors.

Allowing industry funded objective information will serve only to manipulate consumer choices. It will not help consumers make better decisions about medicines but will increase the pharmaceuticalisation of health and will expose more of the population to new medicines (many of which offer little benefit over existing medicines) at a time when long term safety is unknown.

It will also rapidly drive up drug costs with major implications for already stretched health budgets - all of which will be of net harm to the overall public health, they warn.

The goal should be a global collaborative commitment to facilitate access to the independent information prescribers and consumers need to be able to make better informed decisions about medicines, they conclude.

Source: BMJ
VEN /J
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Turmeric: Magic Ingredient to Keep you Healthy in Winter
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.


Recommended Reading
Drug Policy
Drug policy in India...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use